ALS treatment now available in liquid formulation

Teglutik is a new liquid formulation of riluzole that can be prescribed to extend life or the time to mechanical ventilation for patients with amyotrophic lateral sclerosis (ALS).

Riluzole is the only licensed drug for patients with ALS, 80% of whom are unable to swallow as a result of dysphagia. It was previously only available in tablet form.

"The availability of a new liquid form of riluzole will be of great benefit to everyone involved in the care of patients with ALS," said Dr Katie Sidle, Co-Director MNDA MND Care and Research Centre at the National Hospital for Neurology and Neurosurgery, London. "Many will suffer the distress of having to discontinue treatment due to their inability to swallow the current formulation of riluzole, the only treatment option available to treat ALS."

The new liquid formulation is bioequivalent to riluzole tablets.

Further information
View Teglutik drug record
Summary of Product Characteristics
Manufacturer: Martindale Pharmaceuticals

Riluzole is thought to act by inhibiting glutamate processes that have a role in cell death of patients with ALS.

NICE recommends that treatment of ALS be initiated by a specialist but supervision can be managed by GPs under shared care agreements.

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.